Basic, clinical, and epidemiological studies of progressive multifocal leukoencephalopathy: Implications for therapy Jeymohan JosephEugene O. Major Guest Editorial Pages: 1 - 2
An overview: Human polyomavirus JC virus and its associated disorders Mahmut SafakKamel Khalili OriginalPaper Pages: 3 - 9
JC virus agnoprotein colocalizes with tubulin Shuichi EndoYuki OkadaHirofumi Sawa OriginalPaper Pages: 10 - 14
T′ proteins influence JC virus biology Richard J. FrisqueBrigitte BollagLisa H. Kilpatrick OriginalPaper Pages: 15 - 20
Analysis of DNA-binding activity of the JC virus minor capsid protein VP2 Yih-Leh HuangMeilin WangDeching Chang OriginalPaper Pages: 21 - 24
Inflammatory reaction in progressive multifocal leukoencephalopathy: Harmful or beneficial? Renaud A. Du PasquierIgor J. Koralnik OriginalPaper Pages: 25 - 31
Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy S. BaumA. AshokWalter J. Atwood OriginalPaper Pages: 32 - 37
Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions Joseph R. Berger OriginalPaper Pages: 38 - 41
Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment Pasquale FerranteSerena DelbuePaola Cinque OriginalPaper Pages: 42 - 46
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA) Andrea AntinoriAntonella CingolaniItalian Registry Investigative Neuro AIDS (IRINA) Study Group OriginalPaper Pages: 47 - 53
Role of the environment in the transmission of JC virus Sílvia Bofill-MasRosina Girones OriginalPaper Pages: 54 - 58
Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: Is there a biological explanation? S. K. ShankarP. SatishchandraA. Nath OriginalPaper Pages: 59 - 67
Challenges for clinical trials to treat progressive multifocal leukoencephalopathy David B. Clifford OriginalPaper Pages: 68 - 72
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature Paola CinqueSimona BossolascoAdriano Lazzarin OriginalPaper Pages: 73 - 80
Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals Kristina DörriesSilviu SbieraRüdiger Dörries OriginalPaper Pages: 81 - 87
The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology Paola CinqueIgor J. KoralnikDavid B. Clifford OriginalPaper Pages: 88 - 92